Eileen Maloney

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai et al. · Science Translational Medicine · 2017 · 1.8K citations · Full text

Medicine, Immunology, Oncology +17

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

Stephen Bagley, Meghan Logun, Joseph A. Fraietta et al. · Nature Medicine · 2024 · 336 citations · Full text

Medicine, Immunology, Oncology +17

Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

Stephen Bagley, Zev A. Binder, Lamia Lamrani et al. · Nature Cancer · 2024 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans

Robert Siman, Nikhil Toraskar, Antony Dang et al. · Journal of Neurotrauma · 2009 · 156 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

Stephen Bagley, Arati Desai, Joseph A. Fraietta et al. · Nature Medicine · 2025 · 66 citations · Full text

Medicine, Immunology, Oncology +15